The analyst rating for MINIMAX-W was set at Overweight by Morgan Stanley due to the company's rapid iteration pace in launching its new generation Agent flagship large model, M2.7, which demonstrated significant improvements in performance compared to its predecessor, M2.5. The report highlighted that M2.7's advancements in OpenClaw performance are nearing levels close to Sonnet4.6 in benchmark tests. Additionally, Morgan Stanley believes that the company is likely to drive further token growth following the success of OpenClaw, which supports their positive outlook and target price of $990, reflecting a projected 2027 price-to-sales ratio of 56x.
